We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
+0.1%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$68.4B
AUM Growth
-$6.42B
Cap. Flow
-$9.95B
Cap. Flow %
-14.55%
Top 10 Hldgs %
25.74%
Holding
2,605
New
281
Increased
825
Reduced
894
Closed
234

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$433M
2
MRK icon
Merck
MRK
+$286M
3
J icon
Jacobs Solutions
J
+$265M
4
EFX icon
Equifax
EFX
+$253M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$240M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$710M
2
JNJ icon
Johnson & Johnson
JNJ
+$574M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$480M
4
MRVL icon
Marvell Technology
MRVL
+$377M
5
WFC icon
Wells Fargo
WFC
+$333M

Sector Composition

Rank Sector Weight
1 Technology 26.04%
2 Financials 14.64%
3 Healthcare 12%
4 Industrials 10.54%
5 Consumer Discretionary 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACU icon
2076
Acme United Corp
ACU
$213M
– –
-26
Closed -$1K
ADNT icon
2077
Adient
ADNT
$1.58B
– –
-51
Closed -$1K
ADV icon
2078
Advantage Solutions
ADV
$437M
$0 ﹤0.01%
+10
New +$817
ADVM
2079
DELISTED
Adverum Biotechnologies
ADVM
$0 ﹤0.01%
17
– –
AEIS icon
2080
Advanced Energy
AEIS
$13.5B
$0 ﹤0.01%
8
-3,886
-100% -$437K
AIRI icon
2081
Air Industries Group
AIRI
$12.8M
– –
-179
Closed –
ALHC icon
2082
Alignment Healthcare
ALHC
$2.84B
$0 ﹤0.01%
74
-43
-37% -$503
ALLO icon
2083
Allogene Therapeutics
ALLO
$666M
$0 ﹤0.01%
96
– –
ALLT icon
2084
Allot
ALLT
$389M
– –
-346
Closed -$1K
AM icon
2085
Antero Midstream
AM
$10.1B
– –
-6,267
Closed -$94K
AMCR icon
2086
Amcor
AMCR
$22B
$0 ﹤0.01%
21
– –
AOSL icon
2087
Alpha and Omega Semiconductor
AOSL
$974M
– –
-31
Closed -$1K
APAM icon
2088
Artisan Partners
APAM
$3.03B
– –
-57
Closed -$2K
APG icon
2089
APi Group
APG
$18.1B
– –
-8,469
Closed -$186K
APLD icon
2090
Applied Digital
APLD
$8.69B
$0 ﹤0.01%
49
– –
APLS
2091
DELISTED
Apellis Pharmaceuticals
APLS
– –
-3,202
Closed -$92K
APT icon
2092
Alpha Pro Tech
APT
$51M
– –
-402
Closed -$2K
ARCO icon
2093
Arcos Dorados Holdings
ARCO
$1.8B
– –
-72,665
Closed -$633K
ARHS icon
2094
Arhaus
ARHS
$1.21B
– –
-10,440
Closed -$127K
ARIS
2095
DELISTED
Aris Water Solutions
ARIS
– –
-74
Closed -$1K
ARVN icon
2096
Arvinas
ARVN
$551M
– –
-3,031
Closed -$74K
ARWR icon
2097
Arrowhead Research
ARWR
$12.5B
$0 ﹤0.01%
19
– –
ASMB icon
2098
Assembly Biosciences
ASMB
$525M
– –
-71
Closed -$1K
ATEX icon
2099
Anterix
ATEX
$1.9B
– –
-3,114
Closed -$117K
AUTL
2100
Autolus Therapeutics
AUTL
$500M
$0 ﹤0.01%
178
– –
82 83
84
85 86

Similar funds

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Aviva
Aviva London, United Kingdom $59.6B AUM 28.44% 1-Year Est. Return
Mitsubishi UFJ Financial Group
Mitsubishi UFJ Financial Group Tokyo, Japan $62.1B AUM 41.06% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Lazard Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Lazard Asset Management held 2,605 positions worth $68.4B, down 8.6% from $74.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Lazard Asset Management withdrew a net $9.95B in Q4 2024, closing 234 positions and reducing 894 holdings. Its most notable exit was Atlantica Sustainable Infrastructure plc Ordinary Shares, an estimated $210M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lazard Asset Management opened a new position in Vaxcyte worth $39.8M.

  • Lazard Asset Management's largest Q4 2024 buy was Vaxcyte: 486,764 shares worth $39.8M.
  • Lazard Asset Management added most to Eli Lilly in Q4 2024, an estimated $433M increase.
  • Lazard Asset Management's biggest Q4 2024 reduction was Microsoft, cutting an estimated $710M.
  • Lazard Asset Management fully exited Atlantica Sustainable Infrastructure plc Ordinary Shares in Q4 2024, selling an estimated $210M.
  • Lazard Asset Management's ten largest holdings make up 26% of its $68.4B portfolio in Q4 2024.
  • Lazard Asset Management opened 281 new positions and closed 234 in Q4 2024.
  • Lazard Asset Management's portfolio value fell 8.6% quarter-over-quarter to $68.4B.

Based on Lazard Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.